Background: Prediction of ovarian response is one of the prerequisites for women undergoing intracytoplasmic sperm injection (ICSI) treatment prior to the first controlled ovarian stimulation (COS) cycle. Predictive factors may be variable in patients pre-treated with oral contraceptives (OC) for scheduling purposes. Objective: To evaluate antral follicle count (AFC), anti-mülle-rian hormone (AMH) and basal follicle stimulating hormone (FSH) for predicting ovarian responses in patients under controlled ovarian hyperstimulation randomized to receive either oral contraceptives (OC) or no treatment (non-OC) prior to their first controlled ovarian stimulation (COS) cycle. Study Design: One hundred infertile women randomized to receive OC treatment or no treatment, prior to their first COS cycle; were stimulated with Gonadotropin Releasing Hormone (GnRH) antagonist protocol. During the early follicular phase (day 2) of the two subsequent cycles (cycle A & cycle B) sonographic (AFC, ovarian volume) and endocrine data (AMH, basal FSH) were recorded. Transvaginal ultrasound was performed for all patients to monitor the ovarian response. Total number of oocytes retrieved and number of generated embryos were recorded and patients were categorized according to retrieved oocytes as poor (oocytes < 5), normal (oocytes 5 -12) or high responders (oocytes > 12). Result(s): AFC, AMH and basal FSH were lower in users than in non-users of hormonal contraception. Poor responders showed less number of oocytes retrieved and had lower AFC and AMH but a higher basal FSH level was recorded in both groups (OC and non-OC). Conclusion: The better predictive value of AMH or AFC, as a single test or in combination will prevent cycle cancellations due to too low or too high ovarian response.
Introduction
One of the prerequisites for women undergoing intracytoplasmic sperm injection (ICSI) treatment is the fertility potential of women which is dependent on the quantity and the quality of the ovarian reserve (OR) [1] .
The first indicator of the OR taken into consideration is the age of women.
Although the number and quality of oocytes both decrease with age, the fertility potential varies drastically among women of similar age; so, they might exhibit different responses to ovarian stimulation [2] .
An ideal marker for ovarian reserve is of enormous help to reproductive physicians in predicting the outcome of assisted reproductive technology (ART) as it involves huge costs and burden to the couples who seek treatment [3] .
Haadsma et al. showed that among the various methodologies applied to maximize accuracy of OR determinations, none has been universally accepted as superior to others [4] .
Follicle stimulating hormone (FSH) still represents the most widely utilized tool in routine daily practice [5] [6] . Anti-Müllerian hormone (AMH) measurement and antral follicle counts (AFC) have increasingly attracted researchers [4] [7] .
The ovarian reserve is directly correlated with antral follicles in the early follicular phase. The decrease of AFC in basal ultrasound is a sign of ovarian aging, which is observed prior to an increase in FSH levels [8] . It was previously demonstrated that an AFC cut-off value of 3 to 7 indicates a significant decrease in ovarian reserve and subsequently poor ovarian response in in vitro fertilization (IVF) cycles [9] .
Within the ovary, AMH is involved in the regulation of the number of primordial follicles that begin maturation, preventing premature exhaustion of the ovarian reserve. In granulosa cells, AMH is also involved in the regulation of steroidogenesis [10] .
Maturation into small antral follicles is characterized by maximal expression and concentrations of AMH within the follicle, followed rapidly by diminishing expression of AMH and growing dependence on FSH, which promotes further development into large antral and then pre-ovulatory follicles [11] . Thus, AFC is strongly related to circulating AMH levels since the hormone is produced by antral follicles themselves [12] .
A number of environmental and biological factors have been suggested to cause changes in ovarian reserve markers such as the continuous use of certain contraceptives and current cigarette smoking. Bentzen et al. detected that ovarian reserve markers were lower in women using oral contraception than controls [13] .
The basis of ovarian stimulation for assisted reproduction treatment is the administration of exogenous gonadotropins, to permit retrieval of multiple oocytes during a single cycle. It is necessary to maintain FSH and luteinizing hormone (LH) concentrations above a critical threshold, so that multiple competent follicles are selected for growth and maturation. A gonadotrophin-releasing hormone agonist or antagonist is given concurrently to ensure prevention of a premature spike of LH that would induce ovulation [14] . Final oocyte maturation is then typically triggered by the administration of a bolus of human chorionic gonadotropin (HCG), which is structurally and biologically similar to LH and binds to the same LH/HCG receptor [15] .
Wallace and Kelsey showed that indirect determination of ovarian reserve is important in the treatment of infertility, since there is no known method for assessing the ovarian reserve of individual women [16] .
There are conflicting data regarding AFC compared to AMH in predicting ovarian response to gonadotropins in IVF cycles. Mutlu The discrepancies between studies encourage me to do the present research to evaluate the prognostic ability of the antral follicle count, anti-Müllerian hormone and basal follicle stimulating hormone for predicting ovarian responses (the number of retrieved oocytes and the number of generated embryos by ICSI) to hyperstimulation using gonadotrophin-releasing hormone antagonist protocol, in women either pre-treated with oral contraceptives (OC) treatment; or received no treatment (non-OC) prior to their first controlled ovarian stimulation (COS) cycle to prevent cycle cancellations due to too low or too high ovarian response.
Materials and methods

Patients
The randomized controlled study was carried out on one hundred infertile 
Methods
Predictive Factors Used
Predictive factors, including demographic (age, BMI, duration of infertility) sonographic (AFC; ovarian volume) and endocrine factors {AMH, basal FSH; serum estradiol (E2)} were assessed in two subsequent cycles (A, B).
Assessments of Ovarian Stimulation in OC and Non-OC Group
In the OC group, these assessments were made on cycle A day 2 or 3 and at stimulation day 1 on cycle B at least 4 days after the last OC pill intake.
In the non-OC assessments were made on cycle A day 2 or 3 and at stimulation day 1 on cycle B day 2 or 3. Ultrasound machine (Philips HD-3; Koninkijke Philips Electronics N.V.) was used for measuring all visible follicles less than 10 mm in diameter in both ovaries (AFC) and ovarian volume. AMH and basal FSH were measured on the same day in serum by immunoenzymatic assays.
The OC group received Yasmin (drospirenone/ethinyl estradiol) 21 active film coated tablets each containing 3 mg of drospirenone and 0.03 mg of ethinyl estradiol (EE) for 21 days and started daily recombinant follicle stimulating hormone {rFSH follitropin alfa (Gonal F Merk Serano Europe LTD, London, UK)} 4 days after stopping OC treatment (stimulation day 1) if withdrawal bleeding had occurred, if not the start of stimulation was delayed till the beginning of full bleeding otherwise the patient was withdrawn from the study.
The non-OC group started daily rFSH (Gonal F) on stimulation day 1 cycle B (Day 2 or 3 of the next menstrual cycle). In both groups, a single subcutaneous injection of 225 IU rFSH (Gonal F) was given on stimulation day 1 and continued daily up to and including the day of triggering of final oocyte maturation by urinary human chorionic gonadotrophin (hCG). According to ovarian response, assessed by ultrasound and serum E2 levels every 2 days, the dosage of rFSH (Gonal F) was adjusted. The maximum total stimulation period was 18 days.
Starting on stimulation day 5, all patients received continued 0.25 mg cetrotide (Cetrorelix acetate Merk Serano Europe LTD, London, UK) daily injection under the skin of the lower abdomen throughout the ovarian stimulation period to prevent premature ovulation in women which can result in the release of immature eggs.
Oocyte retrieval was performed by an 8 MHz transvaginal ultrasound 34 -36 hours after hCG injection (10,000 IU) when two or more follicles> 16 were seen.
Embryo transfer, 3 or 5 days after oocyte pick up, a maximum of three embryos were replaced under ultrasound guidance. Women of both groups received daily progesterone (≥800 mg/day vaginally or ≥100 mg/day intramuscularly) for ≥6 weeks in case of pregnancy or until menses or up to a negative pregnancy test performed ≥14 days after embryo transfer. Total number of follicles and oocytes retrieved were recorded and patients were categorized as poor (oocytes < 5), normal (oocytes 5 -12) or high responders (oocytes > 12). Correlation between cycles A and B was performed in the two groups (OC and non-OC).
Outcome Measure
The primary outcome measure was the number of generated embryos.
The secondary outcome measures were total number of oocytes retrieved correlated with AFC, AMH, FSH and E2 levels on the day of HCG injection. AFC and AMH were used as variables in the analysis as determinants to predict ovulation response using Anova one way unstacked. Result was considered significant at a P value of <0.05 and highly significant at a P value of P < 0.01.
Statistical Analysis
Results
Our study included 100 randomized patients in the ART program; half of randomized patients received OC (Yasmin tablets) and the other randomized half received no treatment prior to their first COS cycle. The two treatment groups were similar with respect to mean age, BMI and duration of infertility (Table 1 ).
In the OC group sonographic and endocrine predictive factors were still slightly reduced when compared at stimulation day 1 with those at the start of AMH, followed by the other predictor factors (Table 2) .
Clinical outcomes, including the number of retrieved oocytes, the total number of embryos, serum E2 at day of HCG injection and total dose of stimulation in the two groups were presented in Table 3 . There was a significantly positive correlation between the number of oocytes as well as the number of embryos with AMH and AFC and a negative correlation between them and basal FSH in both OC and non-OC groups. Total dose of stimulation was significantly negatively correlated with AMH and AFC in both OC and non-OC groups. The strongest correlation was found with AMH in OC group and AFC in non-OC group.
In OC group, 15 women (30%) had poor response (oocytes retrieved < 5), 30 (60%) had normal response (oocytes retrieved < 5 -12) and 5(10%) had high response (oocytes retrieved > 12). In non-OC group who received no treatment; 8 patients (16%) had poor response, 35 (70%) had normal response and 7 (14%) had high response. Poor responders in IVF showed less number of oocytes retrieved and had lower AFC and AMH but higher basal FSH levels in both groups (OC and Non-OC).
There was no significant difference between poor, normal and high respond- (Table 4 and Table 5 ).
Receiver-operation curve (ROC) analysis was performed for the groups of poor, normal and high responders including AMH, AFC and basal FSH in both OC and non-OC groups. The results of ROC analysis confirmed the prognostic value of these parameters in both groups regarding the number of retrieved oocytes with FSH and AMH superior to other parameters in OC group; while AFC is superior to other parameters in non-OC (Table 6 ).
Discussion
Predictive factors of ovarian response in assisted reproductive technology appeared to be vital for the counseling and management of women in clinical prac-tice as well as to determine the best rFSH-starting dose [23] or the best treatment regimen, i.e. GnRH antagonist versus long GnRH agonist protocol [24] Some women respond poorly to ovarian stimulation, e.g. development of less than four retrieved oocytes [25] , and others may experience a hyper-response, e.g. development of over 15 retrieved oocytes [26] . Early identification of potential low and high responders is relevant to enable individualization of the ovarian stimulation treatment regimen [27] . OC = Oral contraceptives; BMI= body mass index; AFC = antral follicle count; AMH = anti-müllerian hormone; FSH= follicle-stimulating hormone; E 2 = estradiol.; HCG = Human Chorionic Gonadotropin; NS = non-significant; HS = highly significant. BMI = body mass index; AFC = antral follicle count; AMH = anti-müllerian hormone; FSH = follicle-stimulating hormone; E 2 = estradiol; Non-OC =Oral contraceptives; NS = non-significant; S = significant; HS = highly significant. Table 6 . ROC analysis for the evaluation of prognostic value of AMH, AFC and basal FSH on the number of retrieved oocytes.
Items Area under the curve (AUC)
Significance ( Markers of ovarian reserve are regularly used to predict poor ovarian response to gonadotrophin stimulation which is suspected in the presence of high levels of FSH and/or estradiol, or more recently on the basis of a low AFC or reduced levels of AMH [28] .
Oral contraceptives used before assisted reproductive technology cycles may influence some of the ovarian predictor factors. For this reason, this study aims to determine the value of AFC, AMH and basal FSH to predict ovarian response in a group of patients undergoing hyperstimulation using gonadotrophin-releasing hormone antagonist protocol, in women either pre-treated with oral contraceptives treatment; or received no treatment prior to their first COS cycle.
The present study includes 100 women; half of them received OC, and the other half received no treatment prior to their first COS cycle. There was no significant difference between poor responders, normal and high responders regarding age, BMI and duration of infertility in both studied groups. Such findings coincided with those of Andersen et al, who showed that OC and non-OC were similar with respect to mean age, BMI and duration of infertility [29] .
Hendriks et al. concluded that age cannot be taken as a sole predictor of cumulative pregnancy to identify poor prognosis cases [30] . However, unlike our re-sults, Vural et al. found that age was significantly higher in the poor responder group [31] . The age-related decline in female fertility is most likely due to the decline in both the quantity and quality of oocytes. As a result of diminished ovarian reserve, the ability of women to conceive naturally is restricted after the age of 40 [17] . The difference from our result may be attributed to the small sample size and the fact that our patients had a narrow age range with older patient aged 40 years according to inclusion criteria. [36] . Also, AFC is strongly related to circulating AMH levels since the hormone is produced by antral follicles themselves [12] .
Regarding AMH, Fiçicioglu et al found that the mean serum AMH levels of patients with more than five retrieved oocytes were found to be higher than poor responders [21] . Also, Elgindy et al. and Tanriverdi et al. found lower serum AMH levels in poor ovarian responders than in normal responders [37] [38] .
Several studies have emphasized that AMH could be a strong indicator for determining the ovarian response. Choi et al. found a close correlation between the retrieved oocyte number and AMH levels [39] . They also reported a significantly decreased cutoff value for the serum AMH levels of poor responder patients.
Prediction of response to ovarian stimulation with gonadotropins before IVF treatment could help clinicians to establish an optimal treatment strategy and prevent cycle cancellations for poor responders.
In the present study both AFC and AMH were the most significant predictors of poor ovarian response and their predictive accuracy was nearly similar. Our results were similar to those of Lee et al. who found that both serum AMH and AFC were reliable ovarian reserve markers for predicting poor and high ovarian response [40] .
Our results showed that the strongest correlation was found with AMH in OC group and AFC in non-OC group. Such finding coincided with many researchers. Fiçicioglu [41] . The better performance of AMH over AFC in these trials can be explained by the considerable sonographer-dependent variability across centers.
AMH levels remain unmodified due to OC pre-treatment as previously described for pituitary-suppressed patients using GnRH analogues or OC [10] .
However other studies found that AFC is significantly better than AMH as predictors of poor ovarian response [42] .
The physician variability between different IVF clinics may also explain the different performance of AFC in single-center and multicenter studies. While, AFC helps to establish follicle sizes and evaluate size discrepancies, AMH provides information essentially on the number of very small, non-atretic follicles, thus both analyses being complementary to the proper adaptation of the type of stimulation required by the patient [43] .
The maximum number of oocytes that could be retrieved in women is strongly limited by the number of recruitable antral follicles in the ovaries and it is obvious that a gonadotrophin dose higher than the maximum will never compensate for the lack of substrate [44] . A large body of evidence clearly indicates that AMH and AFC may be considered interchangeable and globally perform better than all other known markers of ovarian response in IVF [45] .
Conclusion
In conclusion the better predictive value of AMH or AFC, as a single test or in combination will prevent cycle cancellations due to too low or too high ovarian response and reduce the risk of ovarian hyperstimulation syndrome (OHSS).
Therefore it is recommended to include both AFC and AMH in routine evaluation of infertile couples undergoing IVF trial.
